欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/5264/001
药品名称Bortezomib EVER Pharma 2,5 mg/ml solution for injection
活性成分
    • Bortezomib 2.5 mg/ml
剂型Solution for injection
上市许可持有人Ever Valinject GmbH Oberburgau 3 4866 Unterach Am Attersee Austria
参考成员国 - 产品名称Netherlands (NL)
Bortezomib EVER Pharma 2,5 mg/ml oplossing voor injectie
互认成员国 - 产品名称
    • Hungary (HU)
    • Poland (PL)
    • Denmark (DK)
    • Bulgaria (BG)
      Bortezomib EVER Pharma
    • Belgium (BE)
      Bortezomib EVER Pharma 2,5 mg/ml oplossing voor injectie
    • Czechia (CZ)
      Bortezomib Ever Pharma
    • Ireland (IE)
    • France (FR)
    • Romania (RO)
      Bortezomib EVER Pharma 2,5 mg/ml Solution for injection
    • Spain (ES)
    • Slovakia (SK)
    • Portugal (PT)
    • Croatia (HR)
    • Italy (IT)
    • Slovenia (SI)
    • Sweden (SE)
    • Norway (NO)
      Bortezomib EVER Pharma
    • Finland (FI)
许可日期2021/09/14
最近更新日期2025/03/12
药物ATC编码
    • L01XG01 bortezomib
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase